Skip Nav Destination
Issues
ARTICLE
Antitumor Activity and Metabolic Activation of N-Methanocarbathymidine, a Novel Thymidine Analogue with a Pseudosugar Rigidly Fixed in the Northern Conformation, in Murine Colon Cancer Cells Expressing Herpes Simplex Thymidine Kinase
Roy Noy; Zvi Ben-Zvi; Esther Manor; Fabio Candotti; John C. Morris; Harry Ford, Jr; Victor E. Marquez; David G. Johns; Riad Agbaria
Targeted Therapy against Human Lung Cancer in Nude Mice by High-Affinity Recombinant Antimesothelin Single-Chain Fv Immunotoxin 1
Dominic Fan; Seiji Yano; Hisashi Shinohara; Carmen Solorzano; Melissa Van Arsdall; Corazon D. Bucana; Sen Pathak; Ewa Kruzel; Roy S. Herbst; Amir Onn; Jennifer S. Roach; Masanori Onda; Qing-cheng Wang; Ira Pastan; Isaiah J. Fidler
Review
Editorial Perspective
Advertisement
Email alerts
NOTICE: This notice serves to inform the reader that, in 2023, AACR received a donation by Pfizer of the rights to royalties from the sale within the United States of Bavencio® (avelumab), a pharmaceutical owned by Merck. If any resulting funds are received, they would not be used to directly support any specific publication or author. If an individual article is published that deals with this particular drug, such article will include standard financial disclosures per AACR journal policy. For more detail regarding AACR’s established policies for authors, please go to https://aacrjournals.org/pages/editorial-policies#coi.